RAC 2.20% $1.78 race oncology ltd

Unlisted Options Transactions, page-172

  1. 2,842 Posts.
    lightbulb Created with Sketch. 2892
    Dr T qualified that the Yang research on FTO inhibition overcoming PD-1 resistance did not use Zantrene. So basically no published research that there is any correlation, have to wait and see the results!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.